Evidence map›Paper›PMID 29544533›Full record

ArticleGenome biology2018

Predicting double-strand DNA breaks using epigenome marks or DNA at kilobase resolution.

Raphaël Mourad, Krzysztof Ginalski, Gaëlle Legube, Olivier Cuvier

Open access · goldAbstract read
In one paragraph

Article in Genome biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Computational toxicology (Amsterdam, Netherlands) · 2021
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 2 countries.

Raphaël MouradLBME, Centre de Biologie Intégrative (CBI), Université de Toulouse, CNRS, UPS, 118, route de Narbonne, Toulouse, 31062, France. raphael.mourad@ibcg.biotoul.fr.
Krzysztof GinalskiLaboratory of Bioinformatics and Systems Biology, Centre of New Technologies, University of Warsaw, Zwirki i Wigury 93, Warsaw, 02-089, Poland.
Gaëlle LegubeLBCMCP, Centre de Biologie Intégrative (CBI), Université de Toulouse, CNRS, UPS, 118, route de Narbonne, Toulouse, 31062, France.
Olivier CuvierLBME, Centre de Biologie Intégrative (CBI), Université de Toulouse, CNRS, UPS, 118, route de Narbonne, Toulouse, 31062, France.
Laboratoire de Biologie Moléculaire des Eucaryotes · FRLaboratoire d'informatique de Nantes Atlantique · FRUniversité Toulouse III - Paul Sabatier · FRUniversity of Warsaw · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Double-strand breaks (DSBs) result from the attack of both DNA strands by multiple sources, including radiation and chemicals. DSBs can cause the abnormal chromosomal rearrangements associated with cancer. Recent techniques allow the genome-wide mapping of DSBs at high resolution, enabling the comprehensive study of their origins. However, these techniques are costly and challenging. Hence, we devise a computational approach to predict DSBs using the epigenomic and chromatin context, for which public data are readily available from the ENCODE project. We achieve excellent prediction accuracy at high resolution. We identify chromatin accessibility, activity, and long-range contacts as the best predictors.

Indexed as

DNA Breaks, Double-StrandedEpigenesis, GeneticCell LineChromatinDNAHistone CodeHumansNucleotide MotifsChromatinDNAChromatinDouble-strand breaksEpigeneticsMachine learning

Identifiers

PMID29544533
PMCPMC5856001
OpenAlexW2951787040

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.